Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
34 participants
INTERVENTIONAL
2025-03-31
2025-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Cosmetic Face Care Products on Facial Skin Tone and Spot Brightening
NCT06640244
Process Validation in Dermatology: Assessing Methods for UV Exposure (Artificial Source vs. Sunlight) and Efficacy Evaluation of Anti-Tanning Agents
NCT06384092
Evaluation of the Photoprotection Efficacy with Sunscreen Formulas Under Visible Light Exposure
NCT06803901
Photoprotection Efficacy of Four Sunscreen Formulas Under Visible Light Exposure
NCT06796010
Evaluate the Photoprotection Efficiency of Sunscreen Formulas Under Visible Light Exposure
NCT06796088
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
UV exposure will be conducted using a SOL UV solar simulator (300 - 1200nm; dose level 6 joules/cm2) at various time points during weeks 2 - 5 of the study.
Instrumental assessments of skin brightening, skin hydration and skin barrier function will be conducted at regular intervals throughout the whole study. Non-invasive samples of the stratum corneum will be collected at several timepoints during the study to evaluate biomarkers of skin brightening.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cosmetic product M68
Cosmetic product to be applied twice daily 6 days a week (except on measurement days, when it will be applied once) for the duration of the study.
Cosmetic product M68
Cosmetic skin brightening product to be applied to defined test site
Cosmetic product Z15
Cosmetic product to be applied twice daily 6 days a week (except on measurement days, when it will be applied once) for the duration of the study.
Cosmetic product Z15
Cosmetic skin brightening product to be applied to defined test site
Cosmetic product R52
Cosmetic product to be applied twice daily 6 days a week (except on measurement days, when it will be applied once) for the duration of the study.
Cosmetic product R52
Cosmetic skin brightening product to be applied to defined test site
Cosmetic product J61
Cosmetic product to be applied twice daily 6 days a week (except on measurement days, when it will be applied once) for the duration of the study.
Cosmetic product J61
Cosmetic skin brightening product to be applied to defined test site
Cosmetic product U36
Cosmetic product to be applied twice daily 6 days a week (except on measurement days, when it will be applied once) for the duration of the study.
Cosmetic product U36
Cosmetic skin brightening product to be applied to defined test site
No treatment control
No treatment control
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cosmetic product M68
Cosmetic skin brightening product to be applied to defined test site
Cosmetic product Z15
Cosmetic skin brightening product to be applied to defined test site
Cosmetic product R52
Cosmetic skin brightening product to be applied to defined test site
Cosmetic product J61
Cosmetic skin brightening product to be applied to defined test site
Cosmetic product U36
Cosmetic skin brightening product to be applied to defined test site
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participants in the age group of 18-45 years as on the day of enrolment (both ages inclusive).
* Participants having very little hair, no burns, no cut/abrasion; no moles/tattoo/birth marks/burn marks on the test sites/areas as identified on screening.
* Participants with long and broad forearms.
* Participants having skin photo-type IV and V.
* Participants with Spectrophotometer L\* value- 45 to 55 (both values included) on the identified test sites on the volar forearm.
* Participants having uniform skin color and no sunburn/ erythema on the test sites.
* Participants who do not have very dry or scaly skin, uneven skin tone on their volar forearms or no other signs of significant local irritation or skin disease like psoriasis.
* Participants who agree to refrain from using pumice stone, scrubber while bathing during the study.
* Participants who are willing to avoid direct sun exposure to the test sites.
* Participants who have not participated in any clinical product evaluation test within past 1 month.
* Participants able to read and sign an appropriate informed consent form indicating her willingness to participate and agree to come for regular study visits.
* Participants willing to abide by and comply with the study protocol.
* Participants willing to use umbrella \& wear full covered attire if she has to go in sun.
* Participants who are willing not to participate in any other clinical study during participation in the current study.
Exclusion Criteria
* Participants who have outdoor job, extremely physical (manual) job which could cause excessive sun exposure or sweating
* Participants who are smokers.
* Menopausal women.
* Participants having active skin diseases which will interfere with the test readings.
* Participants on oral and topical medications (e.g Steroids, anti-oxidant, antibiotics) which will compromise the study.
* Systemic treatment which may modify the cutaneous state on the day of inclusion or in the previous 30 days, including retinoid therapy.
* Participants who are pregnant, lactating or nursing.
* Intense sun exposure/ photo allergenicity/toxicity.
* Chronic illness which may influence the cutaneous state.
* Participants participating in any other cosmetic or therapeutic trial.
* Participants with any underlying uncontrolled medical illness including diabetes mellitus, hypertension, liver disease or history of alcoholism, HIV, hepatitis, or any other serious medical illness that will pose a health risk due to study participation as per investigator's discretion.
* For female participants only: be pregnant, planning pregnancy or lactating/nursing. Urine pregnancy testing (UPT) will be performed at the time of screening.
18 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
MS Clinical Research Pvt. Ltd
UNKNOWN
Unilever R&D
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
MS Clinical Research Pvt Ltd
Bangalore, Karnataka, India
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SKN-SKA-4328
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.